Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature

The MECOM (MDS1 and EVI1 complex locus) gene, located at 3q26.2, encodes an oncogenic transcription factor implicated in multiple signaling pathways. Rearrangements involving MECOM/3q26.2, including inversions, translocations, insertions and cryptic chromosomal changes, are observed in myeloid neopl...

Full description

Saved in:
Bibliographic Details
Main Authors: Soumya Mikkilineni, Juan Pablo Pineda-Reyes, Lindsay Wilde, Andres Ferber, Zi-Xuan Wang, Stephen Peiper, Guldeep Uppal, Jerald Gong, Jinglan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1526044/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761895373864960
author Soumya Mikkilineni
Juan Pablo Pineda-Reyes
Lindsay Wilde
Andres Ferber
Zi-Xuan Wang
Stephen Peiper
Guldeep Uppal
Jerald Gong
Jinglan Liu
author_facet Soumya Mikkilineni
Juan Pablo Pineda-Reyes
Lindsay Wilde
Andres Ferber
Zi-Xuan Wang
Stephen Peiper
Guldeep Uppal
Jerald Gong
Jinglan Liu
author_sort Soumya Mikkilineni
collection DOAJ
description The MECOM (MDS1 and EVI1 complex locus) gene, located at 3q26.2, encodes an oncogenic transcription factor implicated in multiple signaling pathways. Rearrangements involving MECOM/3q26.2, including inversions, translocations, insertions and cryptic chromosomal changes, are observed in myeloid neoplasms and are associated with high-risk disease features and poor clinical outcomes. The translocation t(3;12)(q26.2;p13.1) is a rare genetic event, resulting in a fusion of the MECOM gene at 3q26.2 with the ETV6 gene at 12p13.1. To date, only 78 cases of hematologic neoplasms harboring t(3;12) have been reported in the English literature, primarily as case reports or case series. T(3;12) has been associated with abnormalities of chromosome 7, multiple hematopoietic lineage dysplasia, and poor prognosis. Given its rarity, studies on t(3;12) in myeloid neoplasms are limited. In this report, we present two additional cases exhibiting t(3;12), initially identified through routine karyotyping. The clinicopathological, cytogenetic and molecular genetic characteristics were summarized and discussed. A comprehensive review of partner genomic loci and genes mutated in myeloid neoplasms with MECOM rearrangement was conducted. The AF4 gene and the transcription elongation control pathways are proposed as potential therapeutic targets for MECOM-rearranged myeloid neoplasms.
format Article
id doaj-art-4b0bd396ad56444ca3b1e68d8a8722ff
institution DOAJ
issn 2234-943X
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-4b0bd396ad56444ca3b1e68d8a8722ff2025-08-20T03:05:53ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-04-011510.3389/fonc.2025.15260441526044Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literatureSoumya Mikkilineni0Juan Pablo Pineda-Reyes1Lindsay Wilde2Andres Ferber3Zi-Xuan Wang4Stephen Peiper5Guldeep Uppal6Jerald Gong7Jinglan Liu8Hematopathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United StatesDepartment of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United StatesDivision of Hematologic Malignancy and Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United StatesDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Torresdale Hospital, Philadelphia, PA, United StatesMolecular and Genomic Pathology Laboratory, Division of Genomic Pathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesDepartment of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United StatesHematopathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United StatesHematopathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, United StatesClinical Cytogenomics Laboratory, Division of Genomic Pathology, Department of Pathology and Genomic Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesThe MECOM (MDS1 and EVI1 complex locus) gene, located at 3q26.2, encodes an oncogenic transcription factor implicated in multiple signaling pathways. Rearrangements involving MECOM/3q26.2, including inversions, translocations, insertions and cryptic chromosomal changes, are observed in myeloid neoplasms and are associated with high-risk disease features and poor clinical outcomes. The translocation t(3;12)(q26.2;p13.1) is a rare genetic event, resulting in a fusion of the MECOM gene at 3q26.2 with the ETV6 gene at 12p13.1. To date, only 78 cases of hematologic neoplasms harboring t(3;12) have been reported in the English literature, primarily as case reports or case series. T(3;12) has been associated with abnormalities of chromosome 7, multiple hematopoietic lineage dysplasia, and poor prognosis. Given its rarity, studies on t(3;12) in myeloid neoplasms are limited. In this report, we present two additional cases exhibiting t(3;12), initially identified through routine karyotyping. The clinicopathological, cytogenetic and molecular genetic characteristics were summarized and discussed. A comprehensive review of partner genomic loci and genes mutated in myeloid neoplasms with MECOM rearrangement was conducted. The AF4 gene and the transcription elongation control pathways are proposed as potential therapeutic targets for MECOM-rearranged myeloid neoplasms.https://www.frontiersin.org/articles/10.3389/fonc.2025.1526044/fullt(3;12)MECOMETV6cytogeneticsmyeloidneoplasms
spellingShingle Soumya Mikkilineni
Juan Pablo Pineda-Reyes
Lindsay Wilde
Andres Ferber
Zi-Xuan Wang
Stephen Peiper
Guldeep Uppal
Jerald Gong
Jinglan Liu
Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
Frontiers in Oncology
t(3;12)
MECOM
ETV6
cytogenetics
myeloid
neoplasms
title Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
title_full Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
title_fullStr Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
title_full_unstemmed Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
title_short Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature
title_sort case report myeloid neoplasms with the t 3 12 q26 2 p13 1 mecom etv6 translocation report of two new cases and review of the literature
topic t(3;12)
MECOM
ETV6
cytogenetics
myeloid
neoplasms
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1526044/full
work_keys_str_mv AT soumyamikkilineni casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT juanpablopinedareyes casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT lindsaywilde casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT andresferber casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT zixuanwang casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT stephenpeiper casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT guldeepuppal casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT jeraldgong casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature
AT jinglanliu casereportmyeloidneoplasmswiththet312q262p131mecometv6translocationreportoftwonewcasesandreviewoftheliterature